• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION MOMENTUM CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G124
Device Problems Signal Artifact/Noise (1036); Over-Sensing (1438); Pacing Problem (1439); Inaccurate Synchronization (1609)
Patient Problem Atrial Fibrillation (1729)
Event Date 02/09/2023
Event Type  Injury  
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded pacemaker mediated tachycardia (pmt) events following the extension post-ventricular atrial refractory period (pvarp).The atrial fibrillation (af) was induced following the pattern, potentially due to atrial pacing within the atrial vulnerable period.Additionally, far-field r-wave oversensing was observed.Review of the current blanking interval is required to mitigate inappropriate mode switches.Data was reviewed and the pmt events did show appropriate termination.Boston scientific technical services provided recommendations to prevent pacing induced af following a pmt.The healthcare professional should consider in-clinic testing for retrograde conduction, review the patient histograms and activity level trends, and consider the benefit of sensor-driven pacing.Review the current sensor settings.If clinically appropriate, consider reducing the sensor settings to pace slower if a similar situation reoccurs.Consider reviewing a blank after rv pace value to help prevent far-field r-wave oversensing.Review the current atr criteria settings and if clinically appropriate consider extending the criteria.Consider programming on atrial flutter response (afr) which provides immediate dissociation of the atrium and ventricle for atrial rates faster than the programmed afr trigger rate.No adverse patient effects were reported.This device remains in-service.
 
Manufacturer Narrative
This product has not been returned to boston scientific, and as a result, laboratory analysis could not be conducted.Please refer to b5 describe event or problem for more information regarding the specific circumstances of this event.
 
Event Description
It was reported that this cardiac resynchronization therapy defibrillator (crt-d) recorded pacemaker mediated tachycardia (pmt) events following the extension post-ventricular atrial refractory period (pvarp).The atrial fibrillation (af) was induced following the pattern, potentially due to atrial pacing within the atrial vulnerable period.Additionally, far-field r-wave oversensing was observed.Review of the current blanking interval is required to mitigate inappropriate mode switches.Data was reviewed and the pmt events did show appropriate termination.Boston scientific technical services provided recommendations to prevent pacing induced af following a pmt.The healthcare professional should consider in-clinic testing for retrograde conduction, review the patient histograms and activity level trends, and consider the benefit of sensor-driven pacing.Review the current sensor settings.If clinically appropriate, consider reducing the sensor settings to pace slower if a similar situation reoccurs.Consider reviewing a blank after rv pace value to help prevent far-field r-wave oversensing.Review the current atr criteria settings and if clinically appropriate consider extending the criteria.Consider programming on atrial flutter response (afr) which provides immediate dissociation of the atrium and ventricle for atrial rates faster than the programmed afr trigger rate.No adverse patient effects were reported.This device remains in-service.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOMENTUM CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key16769317
MDR Text Key313581055
Report Number2124215-2023-18595
Device Sequence Number1
Product Code NIK
UDI-Device Identifier00802526589102
UDI-Public00802526589102
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P010012/S436
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 05/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/13/2019
Device Model NumberG124
Device Catalogue NumberG124
Device Lot Number487447
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/02/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Other;
-
-